India's drug regulator granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 and 3 clinical trials on children for its anti-COVID drug called Corbevax.
from Zee News :India National https://ift.tt/3kMHHxF
Thursday, September 2, 2021